Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Is VISX [EYE] the Next RMBS? -- Ignore unavailable to you. Want to Upgrade?

To: Kachina who wrote (7)	6/27/2000 6:38:00 PM
From: The Prophet	Read Replies (1) \| Respond to of 24

Thanks. FYI, the adverse ruling was before the International Trade Commission, an administrative body, and not the Courts. I think the courts are better equipped to adjudicate patent issues than the ITC as the threshold is much higher in terms of becoming a US District Court judge. I think I will try to review the papers in the Court case to assess VISX' prospects. Should become more interesting as the year goes on and the battle obtains greater visibility. Ultimately, I think Bausch and Lomb must fold and reach an agreement or risk being put out of business in the event of an adverse verdict.